Cognitive Clinical Trials

CCT Research, officially known as Cognitive Clinical Trials, is a specialized clinical research site network focused on neurology and primary care, particularly Alzheimer's disease and other forms of dementia. Founded in 2017 and headquartered in Scottsdale, Arizona, the company utilizes an innovative model that embeds clinical research centers within senior living communities and large physician practices. This strategy significantly improves patient recruitment and retention by bringing clinical trials directly to the populations they serve, thereby reducing the burden on patients and caregivers. CCT provides pharmaceutical sponsors and contract research organizations (CROs) with a turnkey solution for accessing high-quality data and specialized patient cohorts. In June 2023, CCT Research was acquired by IQVIA, a global leader in clinical research services, to enhance its site network and CNS research capabilities.